Clinical Trial Update: Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax [Phase 2]

View source ↗

Summary

Phase 2 study evaluating weekly docetaxel with four-weekly carboplatin (Carbo-Tax) in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Lung Neoplasms | Phase 2 | Status: COMPLETED